Lipoprotein(a) and Cardiovascular Disease in People Living With HIV: The Next Horizon.
作者信息
Hanna David B, Rodriguez Carlos J
机构信息
Division of Epidemiology, Departments of Epidemiology and Population Health Albert Einstein College of Medicine and Montefiore Medical Center Bronx NY.
Division of Cardiology, Department of Medicine Albert Einstein College of Medicine and Montefiore Medical Center Bronx NY.
出版信息
J Am Heart Assoc. 2024 Dec 3;13(23):e039074. doi: 10.1161/JAHA.124.039074. Epub 2024 Nov 28.
Abstract
摘要
相似文献
1
Lipoprotein(a) and Cardiovascular Disease in People Living With HIV: The Next Horizon.感染艾滋病毒者的脂蛋白(a)与心血管疾病：新的前沿领域。
J Am Heart Assoc. 2024 Dec 3;13(23):e039074. doi: 10.1161/JAHA.124.039074. Epub 2024 Nov 28.
2
Prevalence of, risk factors for, and target organ damage from metabolic syndrome among people living with HIV on ART: A cross-sectional analysis in Chongqing, China.中国重庆地区抗逆转录病毒治疗人群中代谢综合征的流行情况、危险因素及靶器官损害：一项横断面分析。
HIV Med. 2024 May;25(5):529-539. doi: 10.1111/hiv.13605. Epub 2023 Dec 29.
3
Traditional Cardiovascular Risk Factors Are Stronger Related to Carotid Intima-Media Thickness Than to Presence of Carotid Plaques in People Living With HIV.传统心血管风险因素与颈动脉内中膜厚度的相关性强于与 HIV 感染者颈动脉斑块的相关性。
J Am Heart Assoc. 2023 Oct 17;12(20):e030606. doi: 10.1161/JAHA.123.030606. Epub 2023 Oct 7.
4
Challenges of Cardiovascular Disease Risk Evaluation in People Living With HIV Infection.HIV感染者心血管疾病风险评估面临的挑战
Circulation. 2018 May 22;137(21):2215-2217. doi: 10.1161/CIRCULATIONAHA.118.033913.
5
The influence of healthcare financing on cardiovascular disease prevention in people living with HIV.医疗保健融资对 HIV 感染者心血管疾病预防的影响。
BMC Public Health. 2020 Nov 23;20(1):1768. doi: 10.1186/s12889-020-09896-8.
6
Associations of depression and anxiety with cardiovascular risk among people living with HIV/AIDS in Korea.韩国 HIV/AIDS 患者中心血管风险与抑郁和焦虑的相关性研究。
Epidemiol Health. 2021;43:e2021002. doi: 10.4178/epih.e2021002. Epub 2020 Dec 24.
7
Elevated Lipoprotein A in South Asians and the Associated Risk of Cardiovascular Disease: A Systematic Review.南亚人群中脂蛋白A升高与心血管疾病的相关风险：一项系统综述。
Curr Probl Cardiol. 2021 Mar;46(3):100581. doi: 10.1016/j.cpcardiol.2020.100581. Epub 2020 Mar 19.
8
Global Burden of Atherosclerotic Cardiovascular Disease in People Living With HIV: Systematic Review and Meta-Analysis.全球艾滋病毒感染者的动脉粥样硬化性心血管疾病负担：系统评价和荟萃分析。
Circulation. 2018 Sep 11;138(11):1100-1112. doi: 10.1161/CIRCULATIONAHA.117.033369.
9
[Prevalence and epidemiological characteristics of major chronic diseases in people living with HIV in Taizhou, Zhejiang Province, 1998-2022].[1998 - 2022年浙江省台州市HIV感染者中主要慢性病的患病率及流行病学特征]
Zhonghua Liu Xing Bing Xue Za Zhi. 2024 Jul 10;45(7):983-989. doi: 10.3760/cma.j.cn112338-20240227-00086.
10
Comparative performance of cardiovascular risk prediction models in people living with HIV.艾滋病毒感染者心血管风险预测模型的比较性能
South Afr J HIV Med. 2022 Nov 15;23(1):1395. doi: 10.4102/sajhivmed.v23i1.1395. eCollection 2022.
本文引用的文献
1
Lipoprotein(a) Is Elevated and Inversely Related to Coronary Endothelial Function in People With HIV.脂蛋白(a)在HIV感染者中升高且与冠状动脉内皮功能呈负相关。
J Am Heart Assoc. 2024 Dec 3;13(23):e035975. doi: 10.1161/JAHA.124.035975. Epub 2024 Nov 22.
2
HIV-Associated Cardiovascular Disease: Beyond the Macrovascular.与艾滋病病毒相关的心血管疾病：超越大血管病变
J Am Heart Assoc. 2023 Nov 21;12(22):e031876. doi: 10.1161/JAHA.123.031876. Epub 2023 Nov 10.
3
Rapid Improvement of Coronary Endothelial Function With PCSK9 Inhibition in People With HIV Is Associated With Reduced Lipoprotein (a) and Not LDL-cholesterol.在感染HIV的人群中，使用前蛋白转化酶枯草杆菌蛋白酶/kexin 9型（PCSK9）抑制剂后冠状动脉内皮功能的快速改善与脂蛋白（a）降低有关，而非低密度脂蛋白胆固醇（LDL-C）。
Circ Cardiovasc Imaging. 2023 Oct;16(10):e015693. doi: 10.1161/CIRCIMAGING.123.015693. Epub 2023 Sep 29.
4
Cardiovascular outcomes in patients with coronary artery disease and elevated lipoprotein(a): implications for the OCEAN(a)-outcomes trial population.冠状动脉疾病和脂蛋白(a)升高患者的心血管结局：对OCEAN(a)-结局试验人群的影响。
Eur Heart J Open. 2023 Aug 27;3(4):oead077. doi: 10.1093/ehjopen/oead077. eCollection 2023 Jul.
5
Pitavastatin to Prevent Cardiovascular Disease in HIV Infection.匹伐他汀预防 HIV 感染患者的心血管疾病。
N Engl J Med. 2023 Aug 24;389(8):687-699. doi: 10.1056/NEJMoa2304146. Epub 2023 Jul 23.
6
HIV and cardiovascular disease: the role of inflammation.HIV 与心血管疾病：炎症的作用。
Curr Opin HIV AIDS. 2022 Sep 1;17(5):286-292. doi: 10.1097/COH.0000000000000755. Epub 2022 Jul 5.
7
Effect of Pelacarsen on Lipoprotein(a) Cholesterol and Corrected Low-Density Lipoprotein Cholesterol.佩拉卡森对脂蛋白(a)胆固醇和校正的低密度脂蛋白胆固醇的影响。
J Am Coll Cardiol. 2022 Mar 22;79(11):1035-1046. doi: 10.1016/j.jacc.2021.12.032.
8
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association.脂蛋白(a)：一种与遗传相关的、因果性的、普遍存在的动脉粥样硬化性心血管疾病风险因素：美国心脏协会的科学声明。
Arterioscler Thromb Vasc Biol. 2022 Jan;42(1):e48-e60. doi: 10.1161/ATV.0000000000000147. Epub 2021 Oct 14.
9
Noninvasive detection of impaired pulmonary artery endothelial function in people living with HIV.无创检测人免疫缺陷病毒感染者肺动脉内皮功能障碍。
AIDS. 2020 Dec 1;34(15):2231-2238. doi: 10.1097/QAD.0000000000002671.
10
Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association.HIV 感染者的心血管疾病特征、预防和管理：美国心脏协会的科学声明。
Circulation. 2019 Jul 9;140(2):e98-e124. doi: 10.1161/CIR.0000000000000695. Epub 2019 Jun 3.
Zotero 插件